FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043801386> ?p ?o ?g. }

• W3043801386 endingPage "293" @default.
• W3043801386 startingPage "287" @default.
• W3043801386 abstract "Studies looking at the effect of antiseizure medications (ASMs) on the sleep microstructure of subjects with epilepsy are scarce. This study aims to evaluate the impact of eslicarbazepine (ESL) as add-on therapy on the sleep microstructure in temporal lobe epilepsy (TLE). Twelve patients affected by TLE were recruited to undergo overnight polysomnography and a subjective evaluation of nocturnal sleep utilizing the Pittsburgh Sleep Quality Index (PSQI) and daytime somnolence through the Epworth Sleepiness Scale (ESS) before and after three months of treatment with ESL as add-on therapy. Ten healthy controls (HC) matched for age, sex and BMI were recruited. Scoring and analysis of sleep macrostructure and cyclic alternating pattern (CAP) parameters were performed. Ten patients completed the study. The comparison between patients in basal condition (T0) and HC showed a significant lower sleep efficiency (p = 0.049), REM percentage (p = 0.002), higher REM latency (p = 0.02), N2 (p = 0.001) and WASO (p = 0.01). Regarding CAP, patients at T0 showed higher CAP rate in N1 (p = 0.01), lower A1 (%) (p = 0.03), higher A3 (%) (p = 0.01), higher mean duration of A (p = 0.02) and A3 (p = 0.006), A3 index (p = 0.02) than HC. ESL did not induce any significant changes in nocturnal macrostructural polysomnographic variables and PSQI scores. Furthermore, the ESS score showed no modification after treatment. Lower CAP rate in N3 (p = 0.02), phase A2 index (p = 0.02) average number of CAP cycle per sequences and mean duration of CAP sequences (both p = 0.02) was evident after ESL. A trend toward significance was evident for the decrease of CAP rate in N1 (p = 0.09) and N2 (p = 0.09), and for the increase of B phase mean duration (p = 0.07). We found significant improvement in sleep continuity as measured by CAP after ESL. These findings suggest that ESL may positively modulate sleep fragmentation in patients with TLE, and hence enhance sleep quality. Our results suggest a favourable sleep profile with the use of ESL." @default.
• W3043801386 created "2020-07-23" @default.
• W3043801386 creator A5001899447 @default.
• W3043801386 creator A5016414310 @default.
• W3043801386 creator A5025565227 @default.
• W3043801386 creator A5034618629 @default.
• W3043801386 creator A5042619844 @default.
• W3043801386 creator A5050259375 @default.
• W3043801386 creator A5063091017 @default.
• W3043801386 creator A5068240335 @default.
• W3043801386 creator A5076959356 @default.
• W3043801386 date "2020-11-01" @default.
• W3043801386 modified "2023-10-16" @default.
• W3043801386 title "Effects of eslicarbazepine as add-on therapy on sleep architecture in temporal lobe epilepsy: results from “Esleep” study" @default.
• W3043801386 cites W1545241942 @default.
• W3043801386 cites W1578437353 @default.
• W3043801386 cites W1696700191 @default.
• W3043801386 cites W1967463997 @default.
• W3043801386 cites W1969926969 @default.
• W3043801386 cites W197066864 @default.
• W3043801386 cites W1975128774 @default.
• W3043801386 cites W1979000344 @default.
• W3043801386 cites W1984234523 @default.
• W3043801386 cites W1985901821 @default.
• W3043801386 cites W1995187814 @default.
• W3043801386 cites W1999176892 @default.
• W3043801386 cites W2025008455 @default.
• W3043801386 cites W2031053683 @default.
• W3043801386 cites W2052026914 @default.
• W3043801386 cites W2055596068 @default.
• W3043801386 cites W2058709114 @default.
• W3043801386 cites W2058964932 @default.
• W3043801386 cites W2071988308 @default.
• W3043801386 cites W2075556621 @default.
• W3043801386 cites W2079879582 @default.
• W3043801386 cites W2088697742 @default.
• W3043801386 cites W2092945908 @default.
• W3043801386 cites W2095063593 @default.
• W3043801386 cites W2106099321 @default.
• W3043801386 cites W2117296910 @default.
• W3043801386 cites W2142425989 @default.
• W3043801386 cites W2148904065 @default.
• W3043801386 cites W2151487996 @default.
• W3043801386 cites W2345517476 @default.
• W3043801386 cites W2427306579 @default.
• W3043801386 cites W2434380460 @default.
• W3043801386 cites W2514373550 @default.
• W3043801386 cites W2541570982 @default.
• W3043801386 cites W2575070709 @default.
• W3043801386 cites W2604213817 @default.
• W3043801386 cites W2736441536 @default.
• W3043801386 cites W2737518333 @default.
• W3043801386 cites W2741763767 @default.
• W3043801386 cites W2752493804 @default.
• W3043801386 cites W2777861720 @default.
• W3043801386 cites W2794975831 @default.
• W3043801386 cites W2889747466 @default.
• W3043801386 cites W2902426855 @default.
• W3043801386 cites W3006665003 @default.
• W3043801386 cites W3015023391 @default.
• W3043801386 cites W4295332390 @default.
• W3043801386 cites W7692620 @default.
• W3043801386 doi "https://doi.org/10.1016/j.sleep.2020.06.033" @default.
• W3043801386 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32927378" @default.
• W3043801386 hasPublicationYear "2020" @default.
• W3043801386 type Work @default.
• W3043801386 sameAs 3043801386 @default.
• W3043801386 citedByCount "10" @default.
• W3043801386 countsByYear W30438013862021 @default.
• W3043801386 countsByYear W30438013862022 @default.
• W3043801386 crossrefType "journal-article" @default.
• W3043801386 hasAuthorship W3043801386A5001899447 @default.
• W3043801386 hasAuthorship W3043801386A5016414310 @default.
• W3043801386 hasAuthorship W3043801386A5025565227 @default.
• W3043801386 hasAuthorship W3043801386A5034618629 @default.
• W3043801386 hasAuthorship W3043801386A5042619844 @default.
• W3043801386 hasAuthorship W3043801386A5050259375 @default.
• W3043801386 hasAuthorship W3043801386A5063091017 @default.
• W3043801386 hasAuthorship W3043801386A5068240335 @default.
• W3043801386 hasAuthorship W3043801386A5076959356 @default.
• W3043801386 hasConcept C118552586 @default.
• W3043801386 hasConcept C126322002 @default.
• W3043801386 hasConcept C15744967 @default.
• W3043801386 hasConcept C197934379 @default.
• W3043801386 hasConcept C2776245837 @default.
• W3043801386 hasConcept C2777334680 @default.
• W3043801386 hasConcept C2778186239 @default.
• W3043801386 hasConcept C2778205975 @default.
• W3043801386 hasConcept C2778664715 @default.
• W3043801386 hasConcept C2779034229 @default.
• W3043801386 hasConcept C2781099131 @default.
• W3043801386 hasConcept C2781210498 @default.
• W3043801386 hasConcept C2781326671 @default.
• W3043801386 hasConcept C2983189541 @default.
• W3043801386 hasConcept C42219234 @default.
• W3043801386 hasConcept C71924100 @default.
• W3043801386 hasConceptScore W3043801386C118552586 @default.
• W3043801386 hasConceptScore W3043801386C126322002 @default.

• next